At MolBAiozyme, we leverage the power of chemoinformatics to accelerate drug discovery and development. Our advanced computational techniques and analyses provide crucial insights into the chemical and biological properties of potential drug candidates, streamlining the path from discovery to development. Below are our comprehensive services, meticulously designed to meet the demanding needs of the pharmaceutical industry.
Efficient management of chemical structure databases is fundamental for storing, retrieving, and analysing chemical data.
Virtual screening helps identify potential drug candidates from large chemical libraries by predicting their biological activity.
Ligand-Based Screening:
Structure-Based Screening:
High-Throughput Screening:
QSAR modelling predicts the biological activity of chemical compounds based on their chemical structure.
Molecular docking predicts the preferred orientation of a molecule to a target protein, aiding in the understanding of drug-receptor interactions.
Pharmacophore modelling identifies the spatial arrangement of features necessary for a molecule to interact with a specific biological target.
Pharmacophore Identification:
Pharmacophore Screening:
Hit Identification:
ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) prediction assesses the drug-like properties of compounds early in the discovery process.
De novo drug design involves designing new drug-like molecules from scratch based on desired biological activity and target structure. Designing chemical libraries to cover a broad chemical space and enhance the probability of finding active compounds.
Molecular dynamics simulations provide insights into the dynamic behavior of drug-target complexes over time.
Simulation Setup:
Trajectory Analysis:
Binding Free Energy Calculation:
© Copyright 2024 MolBAiozyme | All Rights Reserved. Powered by: Ciesto Solutions